Inhibitors | Comment | Organism | Structure |
---|---|---|---|
(+)-acetylcarnitine | competitive inhibition | Sus scrofa | |
(+)-carnitine | - |
Sus scrofa | |
(-)-acetylcarnitine | noncompetitive inhibition | Sus scrofa | |
5,5'-dithio-bis(2-nitrobenzoic acid) | - |
Sus scrofa | |
acetylcarnitine | - |
Sus scrofa | |
carnitine nitrile | - |
Sus scrofa | |
choline | - |
Sus scrofa | |
deoxycarnitine | competitive inhibition | Sus scrofa | |
DL-acetyl-beta-methylcholine | - |
Sus scrofa | |
DL-acetylcarnitine | competitive inhibition | Sus scrofa | |
DL-carnitine | - |
Sus scrofa | |
gamma-aminobutyrate | - |
Sus scrofa | |
HgCl2 | - |
Sus scrofa | |
iodoacetamide | - |
Sus scrofa | |
N-ethylmaleimide | - |
Sus scrofa | |
p-hydroxymercuribenzoate | - |
Sus scrofa | |
Prostigmine | - |
Sus scrofa | |
tensilon | - |
Sus scrofa |
KM Value [mM] | KM Value Maximum [mM] | Substrate | Comment | Organism | Structure |
---|---|---|---|---|---|
0.041 | - |
CoASH | - |
Sus scrofa | |
0.31 | - |
(-)carnitine | - |
Sus scrofa | |
1.6 | - |
(-)-norcarnitine | - |
Sus scrofa | |
3.2 | - |
DL-norcarnitine | - |
Sus scrofa | |
40 | - |
DL-beta-hydroxy-gamma-aminobutyrate | - |
Sus scrofa |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
acetyl-CoA + carnitine | Sus scrofa | - |
O-acetylcarnitine + CoASH | - |
r | |
acyl-CoA + carnitine | Sus scrofa | - |
acylcarnitine + CoASH | - |
r | |
acylcarnitine + CoASH | Sus scrofa | - |
acyl-CoA + carnitine | - |
r | |
O-acetylcarnitine + CoASH | Sus scrofa | - |
acetyl-CoA + carnitine | - |
r |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Sus scrofa | - |
pig | - |
Purification (Comment) | Organism |
---|---|
partially | Sus scrofa |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
heart | - |
Sus scrofa | - |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
acetyl-CoA + (-)-norcarnitine | beta-hydroxy-gamma-dimethylaminobutyrate | Sus scrofa | acetylnorcarnitine + CoASH | - |
r | |
acetyl-CoA + carnitine | - |
Sus scrofa | O-acetylcarnitine + CoASH | - |
r | |
acetyl-CoA + DL-beta-hydroxy-gamma-aminobutyrate | non-methylated derivative of carnitine | Sus scrofa | beta-hydroxybutyrate + CoASH | - |
r | |
acetyl-CoA + DL-norcarnitine | beta-hydroxy-gamma-dimethylaminobutyrate | Sus scrofa | acetylnorcarnitine + CoASH | - |
r | |
acetyl-CoA + L-(-)carnitine | - |
Sus scrofa | O-acetylcarnitine + CoASH | - |
r | |
acyl-CoA + carnitine | - |
Sus scrofa | acylcarnitine + CoASH | - |
r | |
acylcarnitine + CoASH | - |
Sus scrofa | acyl-CoA + carnitine | - |
r | |
additional information | only (-) optical isomers are substrates, unnatural (+) isomers are competitive inhibitors | Sus scrofa | ? | - |
? | |
O-acetylcarnitine + CoASH | - |
Sus scrofa | acetyl-CoA + L-(-)carnitine | - |
r | |
O-acetylcarnitine + CoASH | - |
Sus scrofa | acetyl-CoA + carnitine | - |
r |
Ki Value [mM] | Ki Value maximum [mM] | Inhibitor | Comment | Organism | Structure |
---|---|---|---|---|---|
0.25 | - |
(+)-acetylcarnitine | - |
Sus scrofa | |
0.39 | - |
DL-acetylcarnitine | - |
Sus scrofa | |
0.62 | - |
DL-carnitine | - |
Sus scrofa | |
1.2 | - |
deoxynorcarnitine | - |
Sus scrofa | |
2.1 | - |
(+)carnitine | - |
Sus scrofa | |
2.3 | - |
deoxycarnitine | - |
Sus scrofa | |
12 | - |
Prostigmine | - |
Sus scrofa | |
15 | - |
tensilon | - |
Sus scrofa | |
27 | - |
choline | - |
Sus scrofa | |
44 | - |
gamma-aminobutyrate | - |
Sus scrofa | |
71 | - |
DL-acetyl-beta-methylcholine | - |
Sus scrofa |